| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |